Oncology Pathology

Histopathology & Immunohistochemistry Services – Medsol HSL

Medsol Histopathology & Specialty Laboratory (HSL) delivers comprehensive oncology pathology services, supporting surgeons, oncologists, and multidisciplinary cancer teams with accurate tissue diagnosis, tumor classification, and biomarker evaluation. Our services are designed to support evidence-based clinical decision-making across the cancer care continuum.

Comprehensive Cancer Histopathology

We provide detailed histopathological evaluation of oncology specimens across all major organ systems, including:

• Core, incisional, and excisional biopsies
• Resection specimens from solid organ and soft tissue tumors
• Breast oncology specimens (biopsy, lumpectomy, mastectomy)
• Gastrointestinal, hepatobiliary, and pancreatic tumors
• Genitourinary malignancies (prostate, bladder, testicular)
• Gynecological malignancies (uterus, ovary, cervix, fallopian tube)
• Head & neck, lung, bone, and soft tissue sarcomas

All cases undergo systematic grossing, processing, and microscopic evaluation, with reporting aligned to international tumor classification and staging standards.

---

Intra-Operative Frozen Section Services

Medsol HSL provides rapid intra-operative frozen section diagnostics, supporting:

• Tissue adequacy confirmation
• Margin assessment
• Immediate surgical decision-making

Frozen section interpretations are systematically correlated with final paraffin sections to ensure diagnostic accuracy and reliability.

Immunohistochemistry (IHC) & Tumor Marker Analysis

• Extensive IHC panels for tumor diagnosis, classification, and prognostic evaluation
• Malignant cases confirmed using fully automated Ventana IHC platforms (Roche) for standardization and reproducibility
• Biomarker assessment to support therapeutic stratification, where clinically indicated
• Validated antibodies, controls, and documentation in line with CAP and ISO 15189 requirements

Special Stains & Ancillary Techniques

• Comprehensive range of special histochemical stains supporting differential diagnosis
• Ancillary techniques applied as per defined diagnostic algorithms and clinical context

Quality, Governance & Compliance

Accreditation-Aligned Practice

• Services aligned with DHA regulatory requirements, CAP best practice guidelines, and ISO 15189 quality management systems
• Defined SOPs covering pre-analytical, analytical, and post-analytical processes
• Documented specimen traceability, reagent validation, and result verification

Diagnostic Expertise

• Reporting by experienced consultant histopathologists
• Multidisciplinary diagnostic approach for complex oncology cases
• Correlation with clinical history, radiology, and laboratory findings

Turnaround Time (TAT)

• Optimized workflows to deliver clinically relevant turnaround times
• Priority processing for biopsies, frozen sections, and oncology cases
• Clear communication of expected TATs to referring clinicians and hospitals

Data Integrity & Confidentiality

• Secure laboratory information systems ensuring data accuracy, traceability, and confidentiality
• Compliance with patient data protection and confidentiality standards

Clinician Support & Collaboration

• Structured, synoptic-style oncology reports where applicable
• Direct access to pathologists for case discussion and diagnostic clarification
• Support for tumor boards, multidisciplinary meetings, and clinical audits